Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Older skin has higher cancer risk due to inflammation and stem cell issues.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.